Financials

The American Chemical Society (ACS) ended 2023 with solid financial results. The Society generated a change in net assets without donor restrictions from operations of $63.8 million on revenues of $791.3 million and expenses of $727.5 million. This performance was achieved due to a continuation of growth from the information services divisions and lower than expected net expenses across Society programs and administration.

The Society’s overall financial position improved strongly, with net assets without donor restrictions increasing by $146.1 million from Dec. 31, 2022, to $775.0 million as of Dec. 31, 2023. The year-end balance includes the aforementioned $63.8 million net from operations, along with net investment gains of $66.8 million. The Society ended the year in compliance with all the ACS Board-established financial guidelines.

The audited financial statements and additional finance-related resources can be accessed on the Society’s financial information website.

ACS is grateful for the generous support provided by all donors and sponsors for its programs and awards.